May 29, 2025

IAM Patent 1000 Highlights Lenczner Slaght’s IP Expertise

Canada’s leading litigation firm continues to receive worldwide recognition for its exceptional Intellectual Property expertise.

After a comprehensive qualitative research process that included peer and client feedback, Lenczner Slaght is proud to once again be ranked in the 2025 edition of IAM Patent 1000: The World’s Leading Patent Professionals. The directory identifies world-class firms and individuals who are deemed outstanding in patent litigation based on their depth of expertise, market presence and quality of work.

In addition to the firm’s ranking, five of our expert litigators are recognized for their in-depth knowledge and extensive trial experience in patent matters.

Clients and peers had only positive feedback for our expert team:

“Lenczner Slaght is an excellent litigation boutique. Its team of skilled practitioners work seamlessly together.” The firm is a powerhouse in contentious matters, expertly handling everything from trials to reviews and appeals. “Sana Halwani is an intelligent and fierce advocate for her clients.” “Jordana Sanft has a well-deserved exceptional reputation in and out of court. Her integrity is second to none, and her ability to uplift everyone around her is incredible.” Halwani focuses on tech-heavy matters, while Sanft is a go-to for pharmaceutical litigation. “Andrew Moeser and Martin Brandsma are skilled and knowledgeable litigators, who develop practical and creative solutions when faced with challenging situations.” Moeser’s cross-border nous and Brandsma’s extensive life sciences background allow them to deliver crisp results. Cynthia Tape has a blend of technical prowess and legal acumen, which she uses to masterfully guide her following through every stage of pre-trial litigation. She brings a wealth of expertise in high-stakes pharmaceutical cases, mastering regulatory intricacies and crafting compelling cross-examinations. The team recently collaborated to address multiple cases involving patent infringement and validity allegations for Gilead, a pioneer in HIV and HBV treatments. The matters were successfully settled, after Lenczner Slaght adeptly navigated strategic and legal challenges across several complex patent actions in Canada.

Congratulations to the team!

About IAM Patent 1000

Over five months, IAM conducted in the region of 1,800 interviews with numerous lawyers, patent lawyers and in-house counsel to gather market intelligence on the leading players in the field. Individuals qualify for a listing in the IAM Patent 1000 when they receive sufficient positive feedback from peers and clients with knowledge of their practice and the market within which they operate. Only those individuals identified by market sources for their exceptional skill sets and profound insights into patent matters feature in the IAM Patent 1000.